1. Home
  2. SYRE vs EVH Comparison

SYRE vs EVH Comparison

Compare SYRE & EVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYRE
  • EVH
  • Stock Information
  • Founded
  • SYRE 2013
  • EVH 2011
  • Country
  • SYRE United States
  • EVH United States
  • Employees
  • SYRE N/A
  • EVH N/A
  • Industry
  • SYRE Biotechnology: Pharmaceutical Preparations
  • EVH Other Consumer Services
  • Sector
  • SYRE Health Care
  • EVH Consumer Discretionary
  • Exchange
  • SYRE Nasdaq
  • EVH Nasdaq
  • Market Cap
  • SYRE 1.1B
  • EVH 1.0B
  • IPO Year
  • SYRE 2016
  • EVH 2015
  • Fundamental
  • Price
  • SYRE $23.71
  • EVH $4.18
  • Analyst Decision
  • SYRE Strong Buy
  • EVH Strong Buy
  • Analyst Count
  • SYRE 5
  • EVH 14
  • Target Price
  • SYRE $55.75
  • EVH $13.21
  • AVG Volume (30 Days)
  • SYRE 741.8K
  • EVH 4.4M
  • Earning Date
  • SYRE 11-04-2025
  • EVH 11-06-2025
  • Dividend Yield
  • SYRE N/A
  • EVH N/A
  • EPS Growth
  • SYRE N/A
  • EVH N/A
  • EPS
  • SYRE N/A
  • EVH N/A
  • Revenue
  • SYRE N/A
  • EVH $2,054,052,000.00
  • Revenue This Year
  • SYRE N/A
  • EVH N/A
  • Revenue Next Year
  • SYRE N/A
  • EVH $27.90
  • P/E Ratio
  • SYRE N/A
  • EVH N/A
  • Revenue Growth
  • SYRE N/A
  • EVH N/A
  • 52 Week Low
  • SYRE $10.91
  • EVH $4.01
  • 52 Week High
  • SYRE $33.47
  • EVH $13.62
  • Technical
  • Relative Strength Index (RSI)
  • SYRE 60.31
  • EVH 17.24
  • Support Level
  • SYRE $21.63
  • EVH $7.44
  • Resistance Level
  • SYRE $24.19
  • EVH $5.25
  • Average True Range (ATR)
  • SYRE 1.33
  • EVH 0.48
  • MACD
  • SYRE -0.26
  • EVH -0.23
  • Stochastic Oscillator
  • SYRE 67.01
  • EVH 4.11

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

About EVH Evolent Health Inc

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.

Share on Social Networks: